Literature DB >> 32531460

Rare homozygous nonsense variant in AIMP1 causing Early Onset Epileptic Encephalopathy with Burst Suppression (EOEE-BS).

Siddharth Gupta1, Maria Schwab2, Karen Valdez-Gonzalez2, Eric Segal3.   

Abstract

Pathogenic variants in AIMP1 gene are rare causes of neurologic disorders. Homozygous frameshift and nonsense variants in AIMP1 have been described in severe neurodegenerative disease. This is the third report of a homozygous nonsense variant in AIMP1 [c.115 C > T (p.Gln39*)] in a girl with severe neonatal onset epileptic encephalopathy. Like the two other cases reported, our patient is also of Filipino descent. Clinical features include microcephaly, poor visual motor development, shallow breathing, severe hypertonia in extremities, severe global developmental delay, poor gag and suck reflex, failure to thrive in the neonatal period, and early onset intractable seizures. Brain MRI showed hypoplasia of corpus callosum as well as cerebellar vermis, global volume loss and diminished myelination for her age. Electroencephalogram at four months of age showed background consisting of synchronous and asynchronous intervals of burst suppression with intermittent multifocal spikes predominantly in the bi-temporal region, suggestive of Early Onset Epileptic Encephalopathy with Burst Suppression (EOEE-BS) which has not been previously associated with the c.115 C > T variant in AIMP1. Of note, she presented to us in super refractory status epilepticus which was eventually controlled after administration of ketogenic diet and Epidiolex (cannabidiol). This report expands the genetic landscape of EOEE-BS. This is the first case of this specific variant in which Epidiolex was administered, which along with Ketogenic diet aided in controlling patient's super refractory status epilepticus.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AIMP1; EOEE-BS; Epileptic encephalopathy; Neurodegenerative diseases

Year:  2020        PMID: 32531460     DOI: 10.1016/j.ejmg.2020.103970

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  2 in total

1.  Dietary Management of Children With Super-Refractory Status Epilepticus: A Systematic Review and Experience in a Single UK Tertiary Centre.

Authors:  Natasha E Schoeler; Zoe Simpson; Runming Zhou; Suresh Pujar; Christin Eltze; J H Cross
Journal:  Front Neurol       Date:  2021-03-12       Impact factor: 4.003

2.  Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.

Authors:  Simona Lattanzi; Eugen Trinka; Pasquale Striano; Chiara Rocchi; Sergio Salvemini; Mauro Silvestrini; Francesco Brigo
Journal:  CNS Drugs       Date:  2021-03-22       Impact factor: 5.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.